Target Audience

This accredited continuing education activity is designed for nurses, interested health care providers, and community members.

Educational Objectives

• Describe the impact that migraine has on women.
• Identify common symptoms of migraine.
• Discuss common migraine treatments.

Method of Participation

Release Date: 5/27/2025

Expiration Date: 5/26/2026

The estimated time to complete this enduring material is 60 minutes.

In order to receive continuing education credits, you must complete these steps prior to the activity expiration date.

• View the entire presentation
• Complete the post-test with a score of 2 out of 3 or better
• Complete the online evaluation
• Save and print your certificate. Retain for future documentation.

Any questions regarding credit, please contact Valeta Creason-Wahl 402-559-7487 or vcreason@unmc.edu

Speaker Bio

Dr. Elizabeth Hartman
Associate Professor, UNMC Department of Neurological Sciences
Division Chief, General Neurology and Headache Medicine
Clinic Director, Nebraska Medicine/UNMC Neuroscience Center

Dr. Elizabeth Hartman is passionate about improving the care for individuals and their families struggling with neurological disease. Dr. Hartman completed a fellowship in Multiple Sclerosis/Neuroimmunology and gained additional Headache Medicine certification. She is an Associated Professor in the Department of Neurological Sciences at the University of Nebraska Medical Center and the Neurology Clinic Director. In addition to holistic clinical Neurology care, she is engaged in teaching and research activities at UNMC. As a Nebraska farm kid at heart, Dr. Hartman enjoys digging in the garden and being outdoors when she is not at work or with her family.

Accreditation

In support of improving patient care, this activity has been planned and implemented by University of Nebraska Medical Center and Olson Center for Women’s Health. University of Nebraska Medical Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. The University of Nebraska Medical Center designates this activity for 1.0 ANCC contact hour. Nurses should only claim credit for the actual time spent participating in the activity.

Disclosure Information

As a jointly accredited provider, the University of Nebraska Medical Center (UNMC) ensures accuracy, balance, objectivity, independence, and scientific rigor in its educational activities and is committed to protecting learners from promotion, marketing, and commercial bias. Faculty (authors, presenters, speakers) are encouraged to provide a balanced view of therapeutic options by utilizing either generic names or other options available when utilizing trade names to ensure impartiality.
    All faculty, planners, and others in a position to control continuing education content participating in a UNMC accredited activity are required to disclose all financial relationships with ineligible companies. As defined by the Standards for Integrity and Independence in Accredited Continuing Education, ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. The accredited provider is responsible for mitigating relevant financial relationships in accredited continuing education.  Disclosure of these commitments and/or relationships is included in these activity materials so that participants may formulate their own judgments in interpreting its content and evaluating its recommendations.
    This activity may include presentations in which faculty may discuss off-label and/or investigational use of pharmaceuticals or instruments not yet FDA-approved. Participants should note that the use of products outside currently FDA-approved labeling should be considered experimental and are advised to consult current prescribing information for FDA-approved indications.
    All materials are included with the permission of the faculty. The opinions expressed are those of the faculty and are not to be construed as those of UNMC.

Disclosures

The accredited provider has mitigated and is disclosing identified relevant financial relationships for the following faculty, planners, and others in control of content prior to assuming their roles:

Faculty

The below faculty nothing to disclose:

• Elizabeth Hartman, MD

Planning Committee

• Valeta Creason-Wahl, MMP
• Heidi Keeler, PhD, MSN/MBA, RN
• Lana Molczyk, MA
• Renee Paulin, MSN, RN, CWOCN

Investigational/Off-Label Use of Drugs Disclosures

• Amitriptyline/Nortriptyline – not FDA approved for migraine
• Venlafaxine – not FDA approved for migraine

Financial Support

No commercial support was received for this activity.